MidAtlantic AIDS Education and Training Center: Events

Trainings & Events
Headquarters & Regional Partner Sites
Special Projects
- SPNS
- Ryan White Parts C & D Collaborative
Resources
- National HIV Resources
- MAAETC Program Materials
About
- Services
  - Overview
  - Administration and Structure
- Contact
  - Contact Form
  - Contact Us
Contact Us
- Contact Form

Clinical Considerations for Hepatitis C Treatment

Details

Starts at: June 26, 2025 1:00pm ET

Ends at: June 26, 2025 2:00pm ET

Free Admission

Description

Clinical Considerations for Hepatitis C Treatment

Objectives

Determine the most appropriate treatment option for Hepatitis C based on current practice guidelines
Recognize preferred treatment options for Hepatitis C and HIV co-infection
Identify appropriate candidates for screening for Hepatitis C

Faculty

Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES

Pronouns: He/Him/His (https://pronouns.org/)

Associate Professor

Pharmaceutical Skills Series Lead

Department of Pharmacotherapeutics and Clinical Research

University of South Florida Taneja College of Pharmacy

Email: astle@usf.edu | Office: 813-974-4568 |Cell: 727-410-1824

Intended Audience

Pharmacists, nurses, physicians, physician assistants.

Contact

Person: Jesse Rungkitwattanakul PharmD
Email: dhakrit.rungkitwatt@howard.edu

Targeted Populations

A variety of the listed populations will be discussed at this event.

Young Adults (ages 18 to 24)
Older Adults (ages 50 and over)

Topics

A variety of the listed topics will be discussed at this event.

Acute HIV
Hepatitis C

MIDATLANTIC AIDS EDUCATION AND TRAINING CENTER

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,917,621 with 0% financed with non-governmental sources. The contents in this presentation are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.